Filter
790
Text search:
medicine
prices
Featured
Recommendations
71
New Publications
231
Language
Document type
No document type
406
Studies & Reports
219
Guidelines
76
Strategic & Response Plan
36
Manuals
27
Situation Updates
9
Fact sheets
8
Training Material
6
Resource Platforms
2
Infographics
1
Countries / Regions
Global
43
India
31
Kenya
26
Ukraine
19
Uganda
18
Nepal
18
Malawi
15
Nigeria
14
Syria
14
South Africa
14
Myanmar / Burma
14
Sierra Leone
12
Zambia
12
Western and Central Europe
12
Liberia
11
Ghana
10
Bangladesh
10
Latin America and the Carribbean
10
Ethiopia
9
Cameroon
9
Haiti
8
Tanzania
8
South–East Asia Region
8
Africa
8
Venezuela
8
Congo, Democratic Republic of
7
Indonesia
7
Senegal
6
Zimbabwe
6
Rwanda
6
Mozambique
6
Namibia
6
Philippines
5
Pakistan
5
South Sudan
5
Germany
5
Sudan
5
Asia
5
Burkina Faso
4
Cambodia
4
Botswana
4
Yemen
4
Eastern Europe
4
Afghanistan
3
Lebanon
3
Benin
3
West and Central Africa
3
Middle East and North Africa
3
Moldova
3
Thailand
2
Central African Republic
2
Eswatini/ Swaziland
2
North Macedonia
2
Lesotho
2
East and Southern Africa
2
Eastern Europe and Central Asia
2
Paraguay
2
Southern Africa
2
Tajikistan
2
Guinea
1
Mali
1
USA
1
Somalia
1
Jordan
1
Egypt
1
Chad
1
China
1
Brazil
1
Serbia
1
Colombia
1
Ecuador
1
Libya
1
Guatemala
1
Madagascar
1
Sri Lanka
1
Poland
1
Albania
1
Mongolia
1
Laos
1
Russia
1
Bulgaria
1
Estonia
1
Romania
1
Lithuania
1
Iran
1
Kyrgyzstan
1
Kazakhstan
1
Georgia
1
Vietnam
1
Gabon
1
Turkmenistan
1
Japan
1
Mauritius
1
Bosnia and Herzegovina
1
Authors & Publishers
Publication Years
Category
Countries
320
Clinical Guidelines
70
Public Health
46
Key Resources
27
Women & Child Health
19
Pharmacy & Technologies
15
Capacity Building
2
Toolboxes
HIV
73
COVID-19
56
Pharmacy
56
Mental Health
47
AMR
45
TB
37
Conflict
28
Planetary Health
27
Health Financing Toolbox
21
Global Health Education
18
NCDs
17
Natural Hazards
13
Ebola & Marburg
11
Refugee
11
Caregiver
10
NTDs
9
Disability
7
Malaria
4
Rapid Response
3
Cholera
2
2.0 Rapid Response
2
Polio
1
Advances have been made through expanded interventions delivered through five public health approaches: innovative and intensified disease management; preventive chemotherapy; vector ecology and management; veterinary public health services; and the provision of safe water, sanitation and hygiene. I
...
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards
the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized
...
The Healthy Living Toolkit is developed to educate refugees, immigrants, resettlement agencies, clinics, community based organizations, and other service providers on refugee health issues. The toolkit presents material in a culturally appropriate manner and is intended to help health care-related p
...
Namibia is no exception to the growingglobal concern on the increasing burden of NCDs. Namibia is an upper middle income country with fast economic growth since independence in 1990. The country is bearing the double burden of communicable and noncommunicable diseases and rapid urbanizat
...
Int J Health Policy Manag 2017, 6(10), 587–600
Low-income countries face many contextual challenges to manage healthcare technologies effectively, as the majority are imported and resources are constrained to a greater extent. Previous healthcare technology management (HTM) policies in Benin ha
...
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spreading rapidly and require urgent solutions.
Gr
...
Over the 20 years that followed, this unique partnership has invested more than US$53 billion, saving 44 million lives and reducing the combined death rate from the three diseases by more than half in the countries in which the Global Fund invests.
